MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, INTI has $1,433,363 in assets. $3,411,700 in debts. $1,290,978 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
359.90%
Quick Ratio
359.90%
Cash Ratio
337.67%
Debt to Asset Ratio
238.02%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred revenue
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
1,290,978 2,375,493 2,976,658 3,737,903
Prepaid expenses and other assets
84,975 71,507 87,428 92,025
Total current assets
1,375,953 2,447,000 3,064,086 3,829,928
Operating lease right-of-use assets
57,410 64,307 71,081 77,734
Total assets
1,433,363 2,511,307 3,135,167 3,907,662
Accounts payable
319,803 51,521 19,646 106,249
Accrued expenses and other liabilities
33,536 690,085 40,432 7,725
Current portion of operating lease obligations
28,981 24,724 27,455 25,987
Total current liabilities
382,320 766,330 87,533 139,961
Deferred revenue
3,000,000 3,000,000 3,000,000 3,000,000
Operating lease obligations, less current portion
29,380 36,889 44,181 52,064
Total liabilities
3,411,700 3,803,219 3,131,714 3,192,025
Preferred stock, value-Series APreferred Stock
--0 0
Preferred stock, value-Series BConvertible Preferred Stock
--0 0
Preferred stock, value-Undesignated Preferred Stock
--0 0
Common stock, 0.0001 par value 500,000,000 shares authorized 172,573,545 shares issued and outstanding at march 31, 2026 and december 31, 2025
17,257 17,257 17,257 17,257
Additional paid-in capital
54,110,425 54,110,425 54,110,425 54,110,425
Accumulated deficit
-56,106,019 -55,419,594 -54,124,229 -53,412,045
Total stockholders deficit
-1,978,337 -1,291,912 3,453 715,637
Total liabilities and stockholders deficit
1,433,363 2,511,307 3,135,167 3,907,662
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$1,290,978 Prepaid expenses andother assets$84,975 Total current assets$1,375,953 Operating leaseright-of-use assets$57,410 Total assets$1,433,363 Accumulated deficit-$56,106,019 Total liabilities andstockholders deficit$1,433,363 Total stockholdersdeficit-$1,978,337 Additional paid-in capital$54,110,425 Common stock, 0.0001par value...$17,257 Total liabilities$3,411,700 Deferred revenue$3,000,000 Total currentliabilities$382,320 Operating leaseobligations, less current...$29,380 Accounts payable$319,803 Accrued expenses andother liabilities$33,536 Current portion ofoperating lease...$28,981

Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics, Inc. (INTI)